Susan Bressman
Overview
Explore the profile of Susan Bressman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
85
Citations
3321
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chahine L, Lafontant D, Choi S, Iwaki H, Blauwendraat C, Singleton A, et al.
medRxiv
. 2024 Aug;
PMID: 39108519
Background: Among LRRK2-associated parkinsonism cases with nigral degeneration, over two-thirds demonstrate evidence of pathologic alpha-synuclein, but many do not. Understanding the clinical phenotype and underlying biology in such individuals is...
2.
Cook L, Verbrugge J, Schwantes-An T, Schulze J, Foroud T, Hall A, et al.
Brain
. 2024 Jul;
147(8):2668-2679.
PMID: 39074992
Variants in seven genes (LRRK2, GBA1, PRKN, SNCA, PINK1, PARK7 and VPS35) have been formally adjudicated as causal contributors to Parkinson's disease; however, individuals with Parkinson's disease are often unaware...
3.
Araujo R, Fearon C, Balint B, Bressman S, Friedman J, Jinnah H, et al.
Lancet Neurol
. 2023 Nov;
22(12):1108-1109.
PMID: 37977708
No abstract available.
4.
Vollstedt E, Schaake S, Lohmann K, Padmanabhan S, Brice A, Lesage S, et al.
Mov Disord
. 2023 Jan;
38(2):286-303.
PMID: 36692014
Background: As gene-targeted therapies are increasingly being developed for Parkinson's disease (PD), identifying and characterizing carriers of specific genetic pathogenic variants is imperative. Only a small fraction of the estimated...
5.
Wise A, Lemus H, Fields M, Swan M, Bressman S
Case Rep Neurol
. 2022 Aug;
14(2):291-295.
PMID: 35949204
Carbidopa-levodopa has been used for more than 50 years in the treatment of Parkinson disease (PD) and other movement disorders. Pyridoxal 5'-phosphate (PLP), an active form of vitamin B6 (pyridoxine),...
6.
Pal G, Mangone G, Ouyang B, Ehrlich D, Saunders-Pullman R, Bressman S, et al.
Ann Neurol
. 2022 Jun;
92(2):345-346.
PMID: 35687082
No abstract available.
7.
Navarro E, Udine E, de Paiva Lopes K, Parks M, Riboldi G, Schilder B, et al.
Nat Aging
. 2022 Jan;
1(9):850-863.
PMID: 35005630
An increasing number of identified Parkinson's disease (PD) risk loci contain genes highly expressed in innate immune cells, yet their role in pathology is not understood. We hypothesize that PD...
8.
Pal G, Mangone G, Hill E, Ouyang B, Liu Y, Lythe V, et al.
Ann Neurol
. 2022 Jan;
91(3):424-435.
PMID: 34984729
Objective: This study was undertaken to compare the rate of change in cognition between glucocerebrosidase (GBA) mutation carriers and noncarriers with and without subthalamic nucleus deep brain stimulation (STN-DBS) in...
9.
Cubo E, Miravite J, Calvo S, Cooper K, Raymond D, Ooi H, et al.
Parkinsonism Relat Disord
. 2021 Dec;
93:85-88.
PMID: 34856447
Background: The minimal clinically important difference (MCID) describes the smallest change in an outcome that is considered clinically meaningful. The Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) is the most frequently rating...
10.
Picillo M, Lafontant D, Bressman S, Caspell-Garcia C, Coffey C, Cho H, et al.
J Parkinsons Dis
. 2021 Nov;
12(1):421-436.
PMID: 34744052
Background: Investigation of sex-related motor and non-motor differences and biological markers in Parkinson's disease (PD) may improve precision medicine approach. Objective: To examine sex-related longitudinal changes in motor and non-motor...